{
    "id": "NCLEX_BOWTIE_500179177",
    "questionType": "bowtie",
    "caseId": "HFDEC500",
    "question": "The nurse is caring for a client admitted for acute decompensated heart failure. After reviewing the client's electronic health record, complete the bowtie by selecting the most likely condition, two actions the nurse should take, and two parameters the nurse should monitor.",
    "tabs": [
        {
            "title": "Nurses' Notes",
            "content": "A 78-year-old male with a history of HFrEF (ejection fraction 30%), hypertension, and chronic kidney disease (stage 3) was admitted 24 hours ago with acute decompensated heart failure. He lives alone in a government-subsidized senior housing complex.\n\n**06:30:** Client used the call light to report feeling 'very lightheaded' and that their 'heart is racing and fluttering'. The client states they briefly 'blacked out' for a few seconds while trying to stand to use the urinal. Client denies chest pain but appears anxious and pale. Skin is cool to the touch."
        },
        {
            "title": "Vital Signs",
            "content": [
                {
                    "time": "Yesterday 22:00",
                    "BP": "158/92 mmHg",
                    "HR": "98 bpm (Sinus Tachycardia)",
                    "RR": "24/min",
                    "SpO2": "91% on 2L NC",
                    "Temp": "37.1째C (98.8째F)"
                },
                {
                    "time": "Today 06:15",
                    "BP": "108/64 mmHg",
                    "HR": "132 bpm (Irregular)",
                    "RR": "28/min",
                    "SpO2": "93% on 4L NC",
                    "Temp": "37.0째C (98.6째F)"
                }
            ]
        },
        {
            "title": "Laboratory Results",
            "content": [
                {
                    "lab": "Potassium",
                    "value": "2.7 mEq/L",
                    "reference": "3.5-5.0 mEq/L",
                    "status": "critical"
                },
                {
                    "lab": "Magnesium",
                    "value": "1.2 mEq/L",
                    "reference": "1.7-2.2 mEq/L",
                    "status": "critical"
                },
                {
                    "lab": "Troponin T",
                    "value": "<0.01 ng/mL",
                    "reference": "<0.04 ng/mL",
                    "status": "normal"
                },
                {
                    "lab": "BUN",
                    "value": "52 mg/dL",
                    "reference": "10-20 mg/dL",
                    "status": "high"
                },
                {
                    "lab": "Creatinine",
                    "value": "2.0 mg/dL",
                    "reference": "0.6-1.2 mg/dL",
                    "status": "high"
                },
                {
                    "lab": "Lactate",
                    "value": "1.1 mmol/L",
                    "reference": "0.5-2.2 mmol/L",
                    "status": "normal"
                }
            ]
        },
        {
            "title": "Diagnostic Results",
            "content": "**12-Lead ECG (Today at 06:20):**\nVentricular rate 130-150 bpm, irregular rhythm. QRS complexes show varying amplitude and morphology, appearing to twist around the isoelectric baseline. QT interval is significantly prolonged. Interpretation: Polymorphic Ventricular Tachycardia."
        },
        {
            "title": "Medication Administration Record",
            "content": [
                {
                    "name": "Lisinopril 10 mg PO",
                    "route": "PO",
                    "frequency": "DAILY",
                    "status": "Held due to BP"
                },
                {
                    "name": "Carvedilol 6.25 mg",
                    "route": "PO",
                    "frequency": "BID",
                    "status": "Scheduled at 09:00"
                },
                {
                    "name": "Furosemide 80 mg IV Push",
                    "route": "IV",
                    "frequency": "STAT",
                    "status": "**New Order**"
                }
            ]
        }
    ],
    "bowtie": {
        "prompt": "Drag the potential condition, actions, and parameters to monitor to the bowtie diagram.",
        "options": {
            "potentialConditions": [
                "Cardiogenic Shock",
                "Worsening Pulmonary Edema",
                "Electrolyte-Induced Dysrhythmia",
                "Acute Coronary Syndrome",
                "Adverse reaction to lisinopril"
            ],
            "actionsToTake": [
                "Administer the scheduled carvedilol",
                "Withhold the STAT dose of IV furosemide",
                "Request an order for an amiodarone bolus",
                "Place the client in high-Fowler's position",
                "Prepare for IV magnesium sulfate administration"
            ],
            "parametersToMonitor": [
                "Hourly urine output",
                "Continuous cardiac monitoring",
                "Serum potassium and magnesium levels",
                "Blood pressure every 15 minutes",
                "Auscultate lung sounds"
            ]
        },
        "solution": {
            "condition": "Electrolyte-Induced Dysrhythmia",
            "action1": "Withhold the STAT dose of IV furosemide",
            "action2": "Prepare for IV magnesium sulfate administration",
            "parameter1": "Continuous cardiac monitoring",
            "parameter2": "Serum potassium and magnesium levels"
        }
    },
    "answerBreakdown": {
        "condition": {
            "correct": "Electrolyte-Induced Dysrhythmia",
            "rationale": "The client's critical hypokalemia (2.7 mEq/L) and hypomagnesemia (1.2 mEq/L), syncope, and the ECG finding of Polymorphic Ventricular Tachycardia (consistent with Torsades de Pointes) are classic signs of a life-threatening arrhythmia caused by severe electrolyte depletion, likely from aggressive diuretic therapy for heart failure."
        },
        "distractors": [
            {
                "option": "Cardiogenic Shock",
                "rationale": "While the client is hypotensive and tachycardic, the primary driver of the instability is the lethal arrhythmia, not primary pump failure. The normal lactate level (1.1 mmol/L) also argues against widespread hypoperfusion consistent with established shock."
            },
            {
                "option": "Worsening Pulmonary Edema",
                "rationale": "The client was admitted for this condition, but the current acute event (syncope, arrhythmia) is the priority. The SpO2 of 93% on 4L, while not ideal, is not the most immediate life threat compared to the unstable cardiac rhythm."
            },
            {
                "option": "Acute Coronary Syndrome",
                "rationale": "The client denies chest pain, and the troponin level is negative, making an acute MI unlikely. The ECG changes are characteristic of an arrhythmia, not ischemia (e.g., ST elevation)."
            },
            {
                "option": "Adverse reaction to lisinopril",
                "rationale": "The MAR indicates the lisinopril was held. Furthermore, the clinical presentation is not consistent with common adverse reactions to ACE inhibitors like angioedema or a dry cough."
            },
            {
                "option": "Administer the scheduled carvedilol",
                "rationale": "This is contraindicated. Administering a beta-blocker to a client who is hemodynamically unstable (hypotensive, tachycardic) with a lethal arrhythmia could worsen bradycardia if the rhythm converts, further decrease blood pressure, and has negative inotropic effects."
            },
            {
                "option": "Request an order for an amiodarone bolus",
                "rationale": "This is contraindicated. Amiodarone can prolong the QT interval, which is the underlying cause of Torsades de Pointes. Administering it could worsen the arrhythmia. The correct treatment is magnesium sulfate."
            },
            {
                "option": "Place the client in high-Fowler's position",
                "rationale": "While this is a standard intervention for heart failure to ease the work of breathing, it does not address the root cause of the client's acute decompensation, which is a life-threatening arrhythmia. The priority is hemodynamic and electrical stabilization."
            },
            {
                "option": "Hourly urine output",
                "rationale": "Monitoring urine output is important for assessing renal function and response to diuretics. However, the immediate priority is to monitor the resolution of the lethal arrhythmia, not fluid status. Furthermore, the diuretic has been correctly withheld."
            },
            {
                "option": "Blood pressure every 15 minutes",
                "rationale": "While blood pressure is a key indicator of hemodynamic stability and must be monitored, continuous cardiac monitoring is the most direct parameter to assess the effectiveness of treatment for the arrhythmia itself. The BP is a consequence of the cardiac rhythm."
            },
            {
                "option": "Auscultate lung sounds",
                "rationale": "Monitoring lung sounds is crucial for assessing fluid status in heart failure. However, the immediate life threat is the arrhythmia. The priority is to monitor the cardiac rhythm and the electrolytes that are causing it."
            }
        ],
        "actions": [
            {
                "option": "Withhold the STAT dose of IV furosemide",
                "rationale": "This is a critical 'SAFETY STOP' action. Furosemide is a loop diuretic that excretes potassium and magnesium. Administering another dose to a client with critical hypokalemia and hypomagnesemia would worsen the electrolyte imbalance and exacerbate the life-threatening arrhythmia."
            },
            {
                "option": "Prepare for IV magnesium sulfate administration",
                "rationale": "This is the first-line treatment for Torsades de Pointes, regardless of the serum magnesium level (though in this case, it is critically low). IV magnesium stabilizes the cardiac membrane and can terminate the arrhythmia. This is a priority life-saving action."
            }
        ],
        "parameters": [
            {
                "option": "Continuous cardiac monitoring",
                "rationale": "This is the most critical parameter to monitor. It allows the nurse to directly observe the cardiac rhythm, assess for conversion of the polymorphic VT to sinus rhythm, and monitor the QT interval to determine the effectiveness of the magnesium and electrolyte replacement."
            },
            {
                "option": "Serum potassium and magnesium levels",
                "rationale": "Since the root cause of the arrhythmia is severe electrolyte depletion, monitoring the response to IV replacement therapy is essential. The nurse must ensure these levels are returning to a safe range to prevent recurrence of the arrhythmia."
            }
        ]
    }
}